204.76
price up icon5.87%   11.36
after-market After Hours: 204.56 -0.20 -0.10%
loading

Astrazeneca Plc Stock (AZN) Forecast

The Astrazeneca Plc (AZN) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $92.65, representing a -54.75% decrease from the current price of $204.76. The highest analyst price target is $94.08, and the lowest is $91.22.

Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month AZN Price Target
Average 99.08 (-51.61% Downside)
loading

Is Astrazeneca Plc (AZN) A Buy Now?

Oscillators
Name Value Action
RSI(14) 87.89 Sell
STOCH(9,6) 96.63 Sell
STOCHRSI(14) 87.89 Sell
MACD(12,26) 28.31 Buy
ADX(14) 45.68 Buy
William %R -0.141 Sell
CCI(14) 92.41 Neutral
Buy: 2 Sell: 4 Neutral: 1
Summary: Sell
Moving Averages
Period Simple Exponential
MA10
171.19
Buy
173.02
Buy
MA20
132.24
Buy
147.51
Buy
MA50
107.99
Buy
118.67
Buy
MA100
96.10
Buy
103.02
Buy
MA200
84.83
Buy
91.07
Buy
Buy: 10 Sell: 0 Neutral: 0
Summary: Buy
According to our latest analysis, AZN could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 4 signaling Sell signals and 1 Neutral signals. This might be a good time to open fresh positions on AZN, as trading bullish markets is always a lot easier
  1. RSI (Relative Strength Index): The RSI(14) value of 87.89 indicates that AZN is overbought. This suggests that AZN price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
  2. STOCH (Stochastic Oscillator): The STOCH value of 96.63 indicates that AZN is oversold. This means that AZN price is at or near the highest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 87.89 indicates that AZN is oversold. This suggests that AZN price is at or near the highest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 45.68 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 92.41 indicates that AZN is still overbought but not to an extreme extent.

Long-term AZN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Astrazeneca Plc financial reports and earnings history, Astrazeneca Plc (AZN) stock could reach $132.59 by 2030, $226.65 by 2040 and $315.87 by 2050. See the projected annual prices until 2050 of the Astrazeneca Plc stock below:

  • Astrazeneca Plc (AZN) is expected to reach an average price of $180.52 in 2035, with a high prediction of $181.55 and a low estimate of $173.55. This indicates an $-11.84% rise from the last recorded price of $204.76.
  • Astrazeneca Plc (AZN) stock is projected to chart a bullish course in 2040, with an average price target of $225.23, representing an $10.00% surge from its current level. The forecast ranges from a conservative $221.90 to a sky-high $226.65.
  • Our analysts predict Astrazeneca Plc (AZN) to jump 32.46% by 2045, soaring from $267.02 to an average price of $271.22, potentially reaching $272.05. While $267.02 is the low estimate, the potential upside is significant.
  • Astrazeneca Plc (AZN) stock is expected to climb by 2050, reaching an average of $315.20, a $53.94% jump from its current level. However, a wide range of estimates exists, with high and low targets of $315.87 and $312.50, respectively, highlighting the market's uncertainty.

Astrazeneca Plc Stock (AZN) Year by Year Forecast

Astrazeneca Plc Stock (AZN) Price Forecast for 2026

The predicted value for Astrazeneca Plc (AZN) in 2026 is set at an average of $95.16. Estimates vary from a peak of $103.71 to a trough of $86.61, indicating an -53.53% surge from the present price of $204.76.
Month Average Low High Change from today's price
March, 2026 $92.84 $91.22 $94.08 -54.66%
April, 2026 $92.24 $90.39 $94.04 -54.95%
May, 2026 $89.11 $86.76 $95.91 -56.48%
June, 2026 $89.97 $87.08 $90.79 -56.06%
July, 2026 $93.02 $88.53 $93.41 -54.57%
August, 2026 $93.01 $91.56 $95.70 -54.58%
September, 2026 $92.03 $86.61 $93.80 -55.05%
October, 2026 $92.75 $90.00 $94.47 -54.70%
November, 2026 $95.60 $91.70 $96.74 -53.31%
December, 2026 $99.33 $94.74 $103.71 -51.49%

Astrazeneca Plc Stock (AZN) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Astrazeneca Plc (AZN) is $104.96, with a high forecast of $111.56 and a low forecast of $98.36. This indicates an -48.74% decrease from the last price of $204.76.
Month Average Low High Change from today's price
January, 2027 $107.07 $98.36 $107.52 -47.71%
February, 2027 $110.35 $105.99 $111.56 -46.11%
March, 2027 $108.11 $106.66 $110.91 -47.20%
April, 2027 $107.44 $106.00 $111.45 -47.53%
May, 2027 $107.56 $100.51 $108.10 -47.47%
June, 2027 $104.92 $103.93 $108.38 -48.76%
July, 2027 $105.29 $102.73 $106.33 -48.58%
August, 2027 $104.70 $102.93 $106.44 -48.87%
September, 2027 $100.98 $99.27 $108.40 -50.68%
October, 2027 $102.95 $100.55 $103.22 -49.72%
November, 2027 $105.86 $101.28 $106.25 -48.30%
December, 2027 $105.59 $104.49 $108.60 -48.43%

Astrazeneca Plc Stock (AZN) Price Forecast for 2028

In 2028, Astrazeneca Plc (AZN) is projected to reach an average price of $111.52, with a high projection of $123.35 and a low estimate of $99.69. This indicates an -45.54% fall from the last price of $204.76.
Month Average Low High Change from today's price
January, 2028 $105.13 $99.69 $106.21 -48.66%
February, 2028 $105.96 $103.13 $107.68 -48.25%
March, 2028 $108.64 $104.94 $110.08 -46.94%
April, 2028 $110.79 $109.56 $117.16 -45.89%
May, 2028 $120.29 $109.85 $121.26 -41.26%
June, 2028 $121.62 $119.49 $123.22 -40.60%
July, 2028 $119.95 $118.48 $122.67 -41.42%
August, 2028 $112.80 $112.50 $123.35 -44.91%
September, 2028 $120.12 $112.80 $120.49 -41.34%
October, 2028 $117.14 $116.15 $120.23 -42.79%
November, 2028 $117.30 $115.07 $118.58 -42.71%
December, 2028 $113.77 $113.50 $120.88 -44.44%

Astrazeneca Plc Stock (AZN) Price Forecast for 2029

The 2029 price forecast for Astrazeneca Plc Stock (AZN) is $123.52 on average, with a high prediction of $135.25 and a low estimate of $111.79. This represents an -39.68% decrease from the previous price of $204.76.
Month Average Low High Change from today's price
January, 2029 $114.66 $111.79 $115.99 -44.00%
February, 2029 $114.25 $113.81 $116.11 -44.20%
March, 2029 $119.85 $114.25 $120.82 -41.47%
April, 2029 $118.58 $117.41 $121.49 -42.09%
May, 2029 $116.68 $112.76 $119.25 -43.02%
June, 2029 $119.25 $116.62 $120.90 -41.76%
July, 2029 $122.01 $118.87 $123.41 -40.41%
August, 2029 $123.06 $121.34 $130.61 -39.90%
September, 2029 $131.89 $123.38 $132.86 -35.59%
October, 2029 $133.56 $131.16 $134.89 -34.77%
November, 2029 $133.42 $130.29 $134.23 -34.84%
December, 2029 $124.79 $124.49 $135.25 -39.06%

Astrazeneca Plc Stock (AZN) Price Forecast for 2030

Astrazeneca Plc Stock (AZN) is expected to reach an average price of $134.18 in 2030, with a high forecast of $144.06 and a low forecast of $124.30. This signifies an -34.47% decrease from the last price of $204.76.
Month Average Low High Change from today's price
January, 2030 $130.07 $124.81 $132.59 -36.48%
February, 2030 $129.08 $128.37 $132.38 -36.96%
March, 2030 $129.67 $127.41 $130.60 -36.67%
April, 2030 $126.26 $125.99 $133.37 -38.34%
May, 2030 $127.29 $124.30 $128.59 -37.83%
June, 2030 $127.00 $126.47 $128.86 -37.98%
July, 2030 $133.90 $127.03 $134.39 -34.61%
August, 2030 $130.71 $130.34 $132.75 -36.17%
September, 2030 $129.81 $125.83 $132.30 -36.60%
October, 2030 $134.13 $129.78 $134.76 -34.49%
November, 2030 $142.14 $132.92 $142.78 -30.58%
December, 2030 $134.55 $132.83 $144.06 -34.29%
drug_manufacturers_general NVS
$160.06
price up icon 1.18%
drug_manufacturers_general MRK
$119.31
price up icon 1.84%
$220.89
price down icon 0.70%
drug_manufacturers_general NVO
$48.74
price down icon 0.77%
$366.58
price up icon 0.53%
Cap:     |  Volume (24h):